(Not satire – unfortunately)
(UPDATE – another private company ISS, not INTERSERVE are running the ICR services. My mistake.)
I’m not sure anyone’s noticed, or is even all that interested, but another private company ISS has also taken over the running of the Royal Marsden NHS Trust which specialises in cancer care – and included in the deal was the world renowned UK Institute of Cancer Research.
The ICR is (was?) one of the world’s most influential cancer research institutes and has (had?) charitable status. It is (was?) listed as one of the top four cancer centres in the world. It operates (operated?) as a charitable status and in its mission statement it states (stated?) that its research is for public benefit not private profit:
We are committed to carrying out research which leads to the relief of human suffering from cancer in such a way that it can be exploited to its maximum potential for the benefit of the public.
Considering that a mission statement is part of the ARTICLES OF ASSOCIATION according to the THE COMPANIES ACT 2006, I would have thought there were serious legal implications to a casual transfer of charitable and public assets to a private company.
I hope someone with more legal knowledge than me is on the case. I can’t be the only person to have noticed this. Can I?
Related articles by Tom Pride: